T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.53% |
| 3 | Technology | 15% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
BWX Technologies
BWXT
$15.5B
| $650M | 0.11% |
11,599,018
+3,312,570
| +40% | +$176M |
|
202
RTX Corp
RTX
$301B
| $642M | 0.11% |
8,783,590
+256,233
| +3% | +$19M |
|
|
CXO
203
DELISTED
CONCHO RESOURCES INC.
CXO
| $640M | 0.11% |
4,861,348
+1,111,269
| +30% | +$134M |
|
204
TE Connectivity
TEL
$63.1B
| $639M | 0.11% |
7,693,260
-1,012,510
| -12% | -$81.4M |
|
205
Puma Biotechnology
PBYI
$455M
| $629M | 0.11% |
5,256,567
+1,822,895
| +53% | +$170M |
|
206
Rayonier
RYN
$6.45B
| $628M | 0.11% |
23,950,553
+560,830
| +2% | +$14.6M |
|
207
Bath & Body Works
BBWI
$3.84B
| $624M | 0.11% |
18,559,120
-4,386,042
| -19% | -$147M |
|
208
Atlassian
TEAM
$39.3B
| $616M | 0.11% |
17,528,616
+2,074,482
| +13% | +$73.7M |
|
209
Aptiv
APTV
$10.4B
| $609M | 0.1% |
6,192,936
-1,464,341
| -19% | -$138M |
|
210
EQT Corp
EQT
$34B
| $607M | 0.1% |
17,091,676
+153,278
| +0.9% | +$5.21M |
|
211
NiSource
NI
$20.1B
| $606M | 0.1% |
23,684,849
+1,768,272
| +8% | +$46.5M |
|
212
Edison International
EIX
$26.9B
| $602M | 0.1% |
7,803,199
-310,368
| -4% | -$24.6M |
|
213
Prologis
PLD
$133B
| $594M | 0.1% |
9,365,343
+216,113
| +2% | +$13.3M |
|
214
AbbVie
ABBV
$443B
| $593M | 0.1% |
6,671,274
+939,171
| +16% | +$71.5M |
|
215
Northern Trust
NTRS
$34.4B
| $592M | 0.1% |
6,443,608
-692,472
| -10% | -$62.6M |
|
216
RPM International
RPM
$14.9B
| $589M | 0.1% |
11,471,445
-828,763
| -7% | -$42.4M |
|
217
AvalonBay Communities
AVB
$26.1B
| $589M | 0.1% |
3,300,104
-58,101
| -2% | -$10.9M |
|
|
SHPG
218
DELISTED
Shire pic
SHPG
| $586M | 0.1% |
3,829,386
-215,669
| -5% | -$33.8M |
|
|
CTLT
219
DELISTED
CATALENT, INC.
CTLT
| $577M | 0.1% |
14,459,799
+442,222
| +3% | +$16.4M |
|
|
INFO
220
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $574M | 0.1% |
13,026,264
-2,271,544
| -15% | -$105M |
|
|
TSRO
221
DELISTED
TESARO, Inc.
TSRO
| $570M | 0.1% |
4,417,654
-397,081
| -8% | -$49.3M |
|
|
AABA
222
DELISTED
Altaba Inc
AABA
| $570M | 0.1% |
8,608,266
-341,495
| -4% | -$21M |
|
223
AT&T
T
$167B
| $565M | 0.1% |
19,083,719
-718,330
| -4% | -$20.4M |
|
224
MSCI
MSCI
$40.9B
| $563M | 0.1% |
4,812,757
-1,157,390
| -19% | -$128M |
|
225
Adient
ADNT
$1.48B
| $561M | 0.1% |
6,683,684
-257,722
| -4% | -$18.3M |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.